Citadel Advisors’s Nuveen Corporate Income November 2021 Target Term Fund JHB Stock Holding History

Citadel Advisors’s Portfolio JHB Stock Details JHB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-21,055	Closed	-$198K	–	15506
2021 Q3	$198K	Sell	21,055 -5,180	-20%	-$48.6K	﹤0.01%	12003
2021 Q2	$247K	Buy	+26,235	New	+$247K	﹤0.01%	11726

Citadel Advisors's JHB Position: Q4 2021 in Review

Citadel Advisors sold out of Nuveen Corporate Income November 2021 Target Term Fund (JHB) in Q4 2021, closing a stake of 21,055 shares — an estimated $198K sold.

Citadel Advisors first reported a position in JHB in Q2 2021 and held it in 2 quarters. The position peaked at $247K in Q2 2021. 0 funds tracked by Wall St. Rank hold JHB as of Q4 2021.

Citadel Advisors reported no remaining Nuveen Corporate Income November 2021 Target Term Fund position as of Q4 2021 after selling out during the quarter.
Citadel Advisors sold 21,055 Nuveen Corporate Income November 2021 Target Term Fund shares in Q4 2021, an estimated $198K.
Citadel Advisors first reported a position in Nuveen Corporate Income November 2021 Target Term Fund in Q2 2021 and held it in 2 quarters.
Citadel Advisors's Nuveen Corporate Income November 2021 Target Term Fund position peaked at $247K in Q2 2021.
0 funds tracked by Wall St. Rank held Nuveen Corporate Income November 2021 Target Term Fund as of Q4 2021.

Based on Citadel Advisors's 13F filing for Q4 2021, filed 14 Feb 2022.